Cox John 4
4 · Dyne Therapeutics, Inc. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
Cox John
DirectorCEO & President
Transactions
- Award
Common Stock
2024-12-04+145,300→ 150,300 total - Award
Stock option (right to buy)
2024-12-04+232,100→ 232,100 totalExercise: $29.44Exp: 2034-12-03→ Common Stock (232,100 underlying)
Holdings
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Consists of shares of Common Stock issuable under 145,300 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 4, 2025.
- [F2]Includes 145,300 unvested RSUs.
- [F3]These shares are held in a trust for the benefit of a child of the Reporting Person.
- [F4]This option was granted on December 4, 2024. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 4, 2028.